You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. High-specificity affinity reagents for N-glycosylation site mapping and glycomics

    SBC: GLYCOSENSORS AND DIAGNOSTICS, LLC            Topic: 300

    DESCRIPTION Glycans have several distinct properties that make them excellent targets for disease biomarkers Firstly the location of the glycans on the cell surface makes them the first point of contact of cellular interactions and thus crucial in the control of normal metabolic processes Cell surface molecules are also strategically exposed for surveillance by the immune system allowing for ...

    STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  2. On Demand Energy Activated Liquid Decontaminants and Cleaning Solutions

    SBC: TDA RESEARCH, INC.            Topic: A12aT005

    Decontamination of chemical and biological threats demands a very reactive solution. It is ideal to generate the decontaminants on-site: the activated decontaminant is highly reactive and quickly destroys chemical and biological warfare agents; prior to activation the ingredients can be safely stored for years, shipped, and handled. TDA's electrochemical decontamination (eClO2) technology u ...

    STTR Phase II 2013 Department of DefenseArmy
  3. Soft and Elastomeric Intramuscular Electrode with Therapeutic Delivery Capability

    SBC: TDA RESEARCH, INC.            Topic: A13AT019

    Approximately 5-6% of military injuries involve some form of major peripheral nerve injury with little chance of spontaneous healing. Currently these injuries lead to major impairment of voluntary muscle function in the limbs and extremities, making tasks of walking, reaching, grasping, etc. very difficult or impossible for many patients. It is not enough to focus therapeutic treatment on the se ...

    STTR Phase I 2013 Department of DefenseArmy
  4. SACURE: Situational Awareness for Cyber-secURity Evaluation and training

    SBC: Intelligent Automation, Inc.            Topic: OSD12T08

    The Department of Defense and owners of large, commercial enterprise networks need excellent tools and well trained personnel to enforce cyber-security and counter cyber-attacks. This proposal focuses on supporting security personnel to have great Situational Awareness and training to help them use next generation cyber-security tools. In collaboration with University of Utah researchers with expe ...

    STTR Phase I 2013 Department of DefenseArmy
  5. Naturalistic Neurocognitive Assessment Using Mobile Gaming Platforms

    SBC: Vista Partners LLC            Topic: A12aT029

    The neurocognitive health of U.S. service members plays a vital role in the defense of the United States. It is critical to a service member"s effectiveness, to force readiness, and it is a key component of a service member"s successful reintegration into family life and society following deployment. Increased rates of mild traumatic brain injury (mTBI) and psychological health problems experien ...

    STTR Phase I 2013 Department of DefenseArmy
  6. Bio-Inspired Visual Navigation: From Landmarks via Bearing to Controls

    SBC: Intelligent Automation, Inc.            Topic: A12aT030

    In a low-texture indoor environment, landmark-based navigation is difficult due to lack of distinctive micro-features such as SIFT and SURF. Intelligent Automation, Inc. (IAI) and GRASP Laboratory at the University of Pennsylvania propose a Bio-Inspired Visual Navigation System with the following three innovations: First, we propose a segmentation-based method to extract landmarks as closed contou ...

    STTR Phase I 2013 Department of DefenseArmy
  7. Humanized Monoclonal Antibodies to Treat Acinetobacter Infections

    SBC: BIOLOGICAL ANTI-INFECTIVE MEDICINES, LLC            Topic: NIAID

    DESCRIPTION (provided by applicant): In the last decade, Acinetobacter baumannii has emerged as one of the most highly antibiotic-resistant pathogens in the United States (US) and throughout the world. These infections are increasingly prevalent and highlylethal, killing 50-60% of those infected. Worse, strains of A. baumannii that no known antibiotic will kill have now emerged, and will continue ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Immunotherapeutics to prevent HCV reinfection

    SBC: Integrated Biotherapeutics, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Up to 170 million people worldwide are chronically infected with HCV Hepatitis C virus (HCV) putting the infected individuals at significant risk for cirrhosis, liver failure and liver cancer. End- stage liver diseasecaused by HCV is the leading indication of liver transplantation (LT) in the United States. However, reinfection with HCV occurs universally and ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  9. Preparation and Characterization of 2nd Generation HIV-1 Maturation Inhibitor Dru

    SBC: DFH Pharma, Inc            Topic: NIAID

    DESCRIPTION (provided by applicant): Despite advances in the development of HIV drugs there remains a need for new therapies. Toxicities associated with long term use of many of the approved HIV drugs coupled with the development of resistance drives the need for new and novel antivirals. Maturation inhibitors (MIs) represent one such class of HIV therapies. HIV maturation inhibitors block virus r ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  10. Elucidation of Antisickling Molecules in a Botanical with Antisickling Activity

    SBC: INVENUX, LLC            Topic: NCCAM

    DESCRIPTION: New therapeutic agents are urgently needed for the treatment of sickle cell disease (SCD), the world's most common genetic disease. Our long-term goal is to develop a drug for use in children that prevents the inexorable progression of SCD. SCD affects approximately 100,000 people in the United States and millions worldwide. It kills more children in Africa than HIV, but while HI ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government